Indian Journal of Sleep Medicine

Register      Login

VOLUME 19 , ISSUE 2 ( April-June, 2024 ) > List of Articles


Beyond the Breath: Exploring the Complex Nexus of Obstructive Sleep Apnea and Comorbid Conditions

Sanchit Mohan, Pranav Ish, Rohit Kumar, Nitesh Gupta, Vidushi Rathi, Nupoor Vaghasia

Keywords : Chronic respiratory failure, Metabolic syndrome, Obstructive sleep apnea, Overlap syndrome, Syndrome-Z

Citation Information : Mohan S, Ish P, Kumar R, Gupta N, Rathi V, Vaghasia N. Beyond the Breath: Exploring the Complex Nexus of Obstructive Sleep Apnea and Comorbid Conditions. Indian Sleep Med 2024; 19 (2):26-30.

DOI: 10.5005/jp-journals-10069-0133

License: CC BY-NC 4.0

Published Online: 19-06-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Obstructive sleep apnea (OSA) can have multi-system involvement, including cardiac, renal, pulmonary, neuropsychiatric, and endocrine complications. Several complications have shown a bidirectional relationship with OSA, and multiple mechanisms of bidirectional relationship have been studied in the literature, like fluid retention and redistribution in heart failure and renal and neural mechanisms in stroke and diabetes. The current review aims to explore comorbidities associated with OSA, look for bidirectional relationships, and the impact of therapy.

PDF Share
  1. Franklin KA, Lindberg E. Obstructive sleep apnea is a common disorder in the population - a review on the epidemiology of sleep apnea. J Thorac Dis 2015;7(8):1311–1322. DOI: 10.3978/j.issn.2072-1439.2015.06.11.
  2. Suri TM, Ghosh T, Mittal S, et al. Systematic review and meta-analysis of the prevalence of obstructive sleep apnea in Indian adults. Sleep Med Rev 2023;71:101829. DOI: 10.1016/j.smrv.2023.101829.
  3. McNicholas WT, Bonsignore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: Current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156–178. DOI: 10.1183/09031936.00027406.
  4. Castro-Grattoni AL, Alvarez-Buvé R, Torres M, et al. Intermittent hypoxia-induced cardiovascular remodeling is reversed by normoxia in a mouse model of sleep apnea. Chest 2016;149:1400–1408. DOI: 10.1016/j.chest.2015.11.010.
  5. Jennum P, Tønnesen P, Ibsen R, et al. Obstructive sleep apnea: Effect of comorbidities and positive airway pressure on all-cause mortality. Sleep Med. 2017;36:62–66. DOI: 10.1016/j.sleep.2017. 04.018.
  6. Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: A scientific statement from the American Heart Association. Circulation 2021;144:e56–e67. DOI: 10.1161/CIR.0000000000000988.
  7. Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: The sleep heart health study. Circulation 2010;122: 352–360. DOI: 10.1161/CIRCULATIONAHA.109.901801.
  8. Nicholl DDM, Hanly PJ, Poulin MJ, et al. Evaluation of continuous positive airway pressure therapy on renin–angiotensin system activity in obstructive sleep apnea. Am J Respir Crit Care Med 2014;190: 572–580. DOI: 10.1164/rccm.201403-0526OC.
  9. Arzt M, Young T, Finn L, et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 2006;166:1716–1722. DOI: 10.1001/archinte.166.16.1716.
  10. Schulz R, Blau A, Börgel J, et al. Sleep apnoea in heart failure. Eur Respir J 2007;29:1201–1205. DOI: 10.1183/09031936.00037106.
  11. White LH, Bradley TD. Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea. J Physiol 2013;591:Pt 5, 1179–1193. DOI: 10.1113/jphysiol.2012.245159.
  12. Doherty LS, Kiely JL, Swan V, et al. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005;127:2076–2084. DOI: 10.1378/chest.127.6.2076.
  13. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003;348:1233–1241. DOI: 10.1056/NEJMoa022479.
  14. McEvoy RD, Antic NA, Heeley E, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 2016;375:919–931. DOI: 10.1056/NEJMoa1606599.
  15. Bucca CB, Brussino L, Battisti A, et al. Diuretics in obstructive sleep apnea with diastolic heart failure. Chest 2007;132:440–446. DOI: 10.1378/chest.07-0311.
  16. Congrete S, Bintvihok M, Thongprayoon C, et al. Effect of obstructive sleep apnea and its treatment of atrial fibrillation recurrence after radiofrequency catheter ablation: A meta-analysis. J Evid Based Med 2018;11:145–151. DOI: 10.1111/jebm.12313.
  17. Mansukhani MP, Wang S, Somers VK. Sleep, death, and the heart. Am J Physiol Heart Circ Physiol 2015;309(5):H739–49. DOI: 10.1152/ajpheart.00285.2015.
  18. Hanly P. Sleep apnea and daytime sleepiness in end-stage renal disease. Semin Dial 2004;17:109–114. DOI: 10.1111/j.0894-0959.2004.17206.x.
  19. Nicholl DDM, Ahmed SB, Loewen AHS, et al. Declining kidney function increases the prevalence of sleep apnea and nocturnal hypoxia. Chest 2012;141:1422–1430. DOI: 10.1378/chest.11-1809.
  20. Abuyassin B, Sharma K, Ayas NT, et al. Obstructive sleep apnea and kidney disease: A potential bidirectional relationship? J Clin Sleep Med 2015;11:915–924. DOI: 10.5664/jcsm.4946.
  21. Chu H, Shih CJ, Ou SM, et al. Association of sleep apnoea with chronic kidney disease in a large cohort from Taiwan. Respirology 2016;21: 754–760. DOI: 10.1111/resp.12739.
  22. Santos RS, Motwani SS, Elias RM. Chronic kidney disease and sleeping disordered breathing (SDB). Curr Hypertens Rev 2016;12:43–47. DOI: 10.2174/1573402112666160114094222.
  23. Lyons OD, Chan CT, Yadollahi A, et al. Effect of ultrafiltration on sleep apnea and sleep structure in patients with end-stage renal disease. Am J Respir Crit Care Med 2015;191:1287–1294. DOI: 10.1164/rccm.201412-2288OC.
  24. Beecroft JM, Zaltzman J, Prasad R, et al. Impact of kidney transplantation on sleep apnoea in patients with end-stage renal disease. Nephrol Dial Transplant 2007;22:3028–3033. DOI: 10.1093/ndt/gfm309.
  25. Koga S, Ikeda S, Yasunaga T, et al. Effects of nasal continuous positive airway pressure on the glomerular filtration rate in patients with obstructive sleep apnea syndrome. Intern Med 2013;52:345–349. DOI: 10.2169/internalmedicine.52.8468.
  26. Li M, Hou WS, Zhang XW, et al. Obstructive sleep apnea and risk of stroke: A meta-analysis of prospective studies. Int J Cardiol 2014;172:466–469. DOI: 10.1016/j.ijcard.2013.12.230.
  27. Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apnea-hypopnea and incident stroke: The sleep heart health study. Am J Respir Crit Care Med 2010;182:269–277. DOI: 10.1164/rccm.200911-1746OC.
  28. Arzt M, Young T, Finn L, et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005;172:1447–1451. DOI: 10.1164/rccm.200505-702OC.
  29. Johnson KG, Johnson DC. Frequency of sleep apnea in stroke and TIA patients: A meta-analysis. J Clin Sleep Med 2010;6:131–137. PMID: 20411688.
  30. Seiler A, Camilo M, Korostovtseva L, et al. Prevalence of sleep-disordered breathing after stroke and TIA: A meta-analysis. Neurology 2019;92:e648–e654. DOI: 10.1212/WNL.00000000000 06904.
  31. Kaneko Y, Hajek VE, Zivanovic V, et al. Relationship of sleep apnea to functional capacity and length of hospitalization following stroke. Sleep 2003;26:293–297. DOI: 10.1093/sleep/26.3.293.
  32. Brill AK, Horvath T, Seiler A, et al. CPAP as treatment of sleep apnea after stroke: A meta-analysis of randomized trials. Neurology 2018;90: e1222–e1230. DOI: 10.1212/WNL.0000000000005262.
  33. Ohayon MM. The effects of breathing-related sleep disorders on mood disturbances in the general population. J Clin Psychiatry 2003;64: 1195–1200, quiz, 1274-6. DOI: 10.4088/jcp.v64n1009.
  34. Pan ML, Tsao HM, Hsu CC, et al. Bidirectional association between obstructive sleep apnea and depression: A population-based longitudinal study. Medicine (Baltimore) 2016;95:e4833. DOI: 10.1097/MD.0000000000004833.
  35. Jehan S, Auguste E, Pandi-Perumal SR, et al. Depression, obstructive sleep apnea and psychosocial health. Sleep Med Disord 2017;1:000012.
  36. Povitz M, Bolo CE, Heitman SJ, et al. Effect of treatment of obstructive sleep apnea on depressive symptoms: Systematic review and meta-analysis. PLoS Med 2014;11:e1001762. DOI: 10.1371/journal.pmed.1001762.
  37. Edwards C, Mukherjee S, Simpson L, et al. Depressive symptoms before and after treatment of obstructive sleep apnea in men and women. J Clin Sleep Med 2015;11:1029–1038. DOI: 10.1007/s11325-019-01954-9.
  38. AbdelFattah MR, Jung SW, Greenspan MA, et al. Efficacy of antidepressants in the treatment of obstructive sleep apnea compared to placebo. A systematic review with meta-analyses. Sleep Breath 2020;24:443–453. DOI: 10.1007/s11325-019-01954-9.
  39. Drager LF, Togeiro SM, Polotsky VY, et al. Obstructive sleep apnea: A cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol 2013;62:569–576. DOI: 10.1016/j.jacc.2013.05.045.
  40. Phillips CL, Hoyos CM, Yee BJ, et al. CrossTalk opposing view: Sleep apnoea causes metabolic syndrome. J Physiol 2016;594:4691–4694. DOI: 10.1113/JP272115.
  41. Deegan PC, McNicholas WT. Pathophysiology of obstructive sleep apnoea. Eur Respir J 1995;8:1161–1178. DOI: 10.1183/09031936.95.08071161.
  42. Resta O, Foschino-Barbaro MP, Legari G, et al. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord 2001;25:669–675. DOI: 10.1038/sj.ijo.0801603.
  43. Borel AL, Leblanc X, Almeras N, et al. Sleep apnoea attenuates the effects of a lifestyle intervention programme in men with visceral obesity. Thorax 2012;67:735–741. DOI: 10.1136/thoraxjnl-2011-201001.
  44. Fritscher LG, Mottin CC, Canani S, et al. Obesity and obstructive sleep apnea-hypopnea syndrome: the impact of bariatric surgery. Obes Surg 2007;17:95–99. DOI: 10.1007/s11695-007-9012-7.
  45. Kent BD, Grote L, Bonsignore MR, et al. Sleep apnoea severity independently predicts glycaemic health in nondiabetic subjects: the ESADA study. Eur Respir J 2014;44:130–139. DOI: 10.1183/09031936.00162713.
  46. Kendzerska T, Gershon AS, Hawker G, et al. Obstructive sleep apnea and incident diabetes. A historical cohort study. Am J Respir Crit Care Med 2014;190:218–225. DOI: 10.1164/rccm.201312-2209OC.
  47. Huang T, Lin BM, Stampfer MJ, et al. A Population-based study of the bidirectional association between obstructive sleep apnea and type 2 diabetes in three prospective U.S. cohorts. Diabetes Care 2018;41:2111–2119. DOI: 10.2337/dc18-0675.
  48. Reutrakul S, Mokhlesi B. Obstructive sleep apnea and diabetes: A state of the art review. Chest 2017;152:1070–1086. DOI: 10.1016/j.chest.2017.05.009.
  49. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000;283:1829–1836. DOI: 10.1001/jama.283.14.1829.
  50. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378–1384. DOI: 10.1056/NEJM200005113421901.
  51. Xia W, Huang Y, Peng B, et al. Relationship between obstructive sleep apnoea syndrome and essential hypertension: A dose-response meta-analysis. Sleep Med 2018;47:11–18. DOI: 10.1016/j.sleep.2018.03.016.
  52. Crinion SJ, Kleinerova J, Kent B, et al. Non-dipping nocturnal blood pressure correlates with obstructive sleep apnoea severity in normotensive subjects and may reverse with therapy. ERJ Open Res 2021;7:00338-2021. DOI: 10.1183/23120541.00338-2021.
  53. Lombardi C, Pengo MF, Parati G. Systemic hypertension in obstructive sleep apnea. J Thorac Dis 2018;10:Suppl. 34, S4231–S4243. DOI: 10.21037/jtd.2018.12.57.
  54. Khurshid K, Yabes J, Weiss PM, et al. Effect of antihypertensive medications on the severity of obstructive sleep apnea: A systematic review and meta-analysis. J Clin Sleep Med 2016;12:1143–1151. DOI: 10.5664/jcsm.6054.
  55. Tamisier R, Lévy P. Management of hypertension in obstructive sleep apnoea: predicting blood pressure reduction under continuous positive airway pressure. Eur Respir J 2017;50:1701822. DOI: 10.1183/13993003.01822-2017.
  56. Pengo MF, Soranna D, Giontella A, et al. Obstructive sleep apnoea treatment and blood pressure: Which phenotypes predict a response? A systematic review and meta-analysis. Eur Respir J 2020;55:1901945. DOI: 10.1183/13993003.01945-2019.
  57. Helvaci N, Karabulut E, Demir AU, et al. Polycystic ovary syndrome and the risk of obstructive sleep apnea: A meta-analysis and review of the literature. Endocr Connect. 2017;6(7):437–445.
  58. Susan Sam, Esra Tasali. Role of obstructive sleep apnea in metabolic risk in PCOS, Curr Opin Endocr Metab Res 2021:46–51. DOI: 10.1016/j.coemr.2021.01.002.
  59. Tasali E, Chapotot F, Leproult R, et al. Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2011 Feb;96(2):365–374. DOI: 10.1210/jc.2010-1187.
  60. McArdle N, King S, Shepherd K, et al. Study of a Novel APAP algorithm for the treatment of obstructive sleep apnea in Women. Sleep. 2015;38(11):1775–1781. DOI: 10.5665/sleep.5162.
  61. Biselli P, Grossman PR, Kirkness JP, et al. The effect of increased lung volume in chronic obstructive pulmonary disease on upper airway obstruction during sleep. J Appl Physiol (1985) 2015;119:266–271. DOI: 10.1152/japplphysiol.00455.2014.
  62. Soler X, Gaio E, Powell FL, et al. High prevalence of obstructive sleep apnea in patients with moderate to severe chronic obstructive pulmonary disease. Ann Am Thorac Soc 2015;12:1219–1225. DOI: 10.1513/AnnalsATS.201407-336OC.
  63. Greenberg-Dotan S, Reuveni H, Tal A, et al. Increased prevalence of obstructive lung disease in patients with obstructive sleep apnea. Sleep Breath 2014;18:69–75. DOI: 10.1007/s11325-013-0850-3.
  64. Machado M-CL, Vollmer WM, Togeiro SM, et al. CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur Respir J 2010;35:132–137. DOI: 10.1183/09031936.00192008.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.